| 产品编号 | CFN60069 | |
| CAS编号 | 1009119-64-5 | |
| 分子式 = 分子量 | C40H50N8O6 = 738.88 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Alkaloids | |
| 植物来源 | ||
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 达卡他韦 | CFN60069 | 1009119-64-5 | 1mg | QQ客服:2159513211 |
| 达卡他韦 | CFN60069 | 1009119-64-5 | 5mg | QQ客服:2159513211 |
| 达卡他韦 | CFN60069 | 1009119-64-5 | 10mg | QQ客服:2159513211 |
| 达卡他韦 | CFN60069 | 1009119-64-5 | 20mg | QQ客服:2159513211 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Daclatasvir (BMS-790052, EBP883) is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. | |||
| Targets: | HCV NS5A | |||
| In vitro: |
|
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.3534 mL | 6.767 mL | 13.534 mL | 27.068 mL | 33.835 mL |
| 5 mM | 0.2707 mL | 1.3534 mL | 2.7068 mL | 5.4136 mL | 6.767 mL |
| 10 mM | 0.1353 mL | 0.6767 mL | 1.3534 mL | 2.7068 mL | 3.3835 mL |
| 50 mM | 0.0271 mL | 0.1353 mL | 0.2707 mL | 0.5414 mL | 0.6767 mL |
| 100 mM | 0.0135 mL | 0.0677 mL | 0.1353 mL | 0.2707 mL | 0.3383 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 5,6,7-三甲氧基香豆素; 5,6,7-Trimethoxycoumarin | CFN89309 | 55085-47-7 | C12H12O5 = 236.22 | 5mg | QQ客服:2056216494 |
| 澳洲茄胺; 澳州茄胺; Solasodine | CFN90200 | 126-17-0 | C27H43NO2 = 413.62 | 20mg | QQ客服:2159513211 |
| 5,8,9,14-Tetraacetoxy-3-benzoyloxy-10,15-dihydroxypepluane; 5,8,9,14-Tetraacetoxy-3-benzoyloxy-10,15-dihydroxypepluane | CFN89379 | 219916-77-5 | C35H46O12 = 658.73 | 5mg | QQ客服:2159513211 |
| (+)-南烛木树脂酚9'-O-葡萄糖甙; (+)-Lyoniresinol 9'-O-glucoside | CFN97964 | 87585-32-8 | C28H38O13 = 582.6 | 10mg | QQ客服:3257982914 |